VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

75 hedge funds and large institutions have $180M invested in Viracta Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$209K
Puts
$2.58M
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$31.3M
2
$29.3M
3
$24.5M
4
$21.2M
5
$8.57M
6
$8.1M
7
$7.33M
8
$6.83M
9
$4.96M
10
$4.18M
11
$3.15M
12
$2.48M
13
$2.33M
14
$2.22M
15
$2.16M
16
$1.51M
17
$1.43M
18
$1.23M
19
$1.1M
20
$1.09M
21
$939K
22
$778K
23
$778K
24
$713K
25
$654K
1
2 3